Summary

Stryker Corp is a medical technology company which designs, develops, manufactures and distributes Orthopaedics, Medical and Surgical, Neurotechnology and Spine products. It is headquartered in the United States of America. Stryker has a wide product range that includes implants used in joint replacement and trauma surgeries, endoscopic systems, surgical equipment and surgical navigation systems, patient handling, emergency medical equipment and intensive care disposable products, as well as neurosurgical, neurovascular and spinal devices.. The report, COVID-19 Impact on Stryker Corp's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Stryker Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Stryker Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- The COVID-19 pandemic has put a large portion of Stryker’s revenue at risk.
- The spread of disease in the US, the largest market for Stryker, is especially worrying.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Stryker Corp -
- It provides insights on Stryker Corp's exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Stryker Corp will be affected by the COVID-19 pandemic.